The Effect of (L-PRF) Membrane in The Treatment of Gingival Recession

Ain Shams University

Status: Completed

Conditions: Localized Gingival Recession

Treatments: Procedure: Leukocyte Platelet rich fibrin membrane

Study type: Interventional

Funder types: Other

Identifiers

NCT04224935

453

Details and patient eligibility

About

evaluation of the use of L-PRF membrane with coronally repositioned flap in treatment of localized gingival recession (Class I & II) in comparison with the use of connective tissue graft

Full description

Twenty patients, who are candidates for gingival recession coverage, will participate in this prospective clinical trial.

Group 1(10 patients) :

Coronally repositioned flap will be done and L PRF membrane will be placed into the tissues

Group 2 (Control group)(10 patients) :

Coronally repositioned flap will be done with sub epithelial connective tissue Parameters

• Clinical evaluation of percentage of root coverage and keratinized tissue width
• Esthetic outcome evaluation Will be done using the root coverage esthetic score (Cairo et al. 2009) that include

Both evaluations will be done at 3, 6 and 9 months

Enrollment: 20 patients

Sex: All

Ages: 20 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Systemically free patients (American Society of Anesthesiologists I; ASA I).
• Age range (20 -40) years.
• Good compliance with the plaque control instructions following initial therapy.
• Patients diagnosed with Miller class I or II in anterior and premolar teeth
• Availability for follow up and maintenance program.

Exclusion criteria

• Patient suffering from periodontitis
• Presence of smoking habit.
• Presence of occlusion interference.
• Pregnant and lactating females.
• Vulnerable group of patients (handicapped, mentally retarded and prisoners).

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

20 participants in 2 patient groups

Leukocyte Platelet Rich Fibrin

Active Comparator group

Description:

Leukocyte Platelet Rich Fibrin will be used

Treatment:

Procedure: Leukocyte Platelet rich fibrin membrane

connective tissue

Active Comparator group

Description:

connective tissue will be used

Treatment:

Procedure: Leukocyte Platelet rich fibrin membrane